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a unique clinical sub group: a case control study
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Abstract 
Background: Women with recurrent ectopic pregnancy (EP) represent a unique cohort of patients in whom 
diagnostic expertise is paramount. We determined whether recurrent EP is associated with significant differences in 
patient demographics, clinical presentation, risk factors and surgical findings when compared with primary EP.
Methods: A retrospective case–control study of all EPs diagnosed from 2003 to 2014, at Whipps Cross University 
Hospital, London.
Results: In the above period 849 EPs were surgically managed (758 primary EPs and 91 recurrent EPs). Recurrent 
EPs were significantly older than primary EPs (32.2 ± 5.08 vs. 30.5 ± 5.83 years, p < 0.05). They presented at a sig-
nificantly earlier gestation (5.99 ± 1.08 vs. 6.52 ± 1.81 weeks, p < 0.05) and with a significantly lower primary βHCG 
(3176 ± 7350 vs. 6243 ± 12,282, p < 0.05). Recurrent EPs were significantly more likely to have a positive history of 
tubal or pelvic surgery (61.5 % vs. 3.5 %, p < 0.05 and 53.8 vs. 14 %, p < 0.05). At surgery, primary EPs had a significantly 
greater volume of hemoperitoneum (592 ± 850 vs. 249 ± 391 ml, p < 0.05), whereas recurrent EPs were significantly 
more likely to have contralateral pathology (31.1 vs. 9.8 %, p < 0.05). Regression analysis showed that the parameters 
of age, gestational age at presentation, first βHCG level, positive history of previous tubal surgery and previous ectopic 
pregnancy differ in women at risk of a recurrent EP when compared to women not at risk of a recurrent ectopic (AUC, 
0.844).
Conclusions: We conclude that recurrent EPs may represent a unique sub-group of patients with EP.
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Background
An ectopic pregnancy is any pregnancy that implants 
outside the uterine cavity. The vast majority of ectopic 
pregnancies implant in the fallopian tube. Despite efforts 
at primary prevention, the incidence of EP has been sta-
ble over recent years, at 11.1 per 1000 pregnancies (The 
Management of Tubal Pregnancy 2004) though there 
has been a significant improvement in the mortality 
from EP as demonstrated in the last UK triennial report 
(Saving Mothers’ Lives 2006). Creanga et  al. estimated 
trends in EP mortality and examined characteristics of 
recently hospitalized women who died as a result of EP 
in the United States and found that the EP mortality ratio 
declined by 56.6 %, from 1.15 to 0.50 deaths per 100,000 
live births between 1980–1984 and 2003–2007 (Creanga 
et al. 2011).
Despite the declining mortality ratio, being diagnosed 
with an EP proves an anxiety-provoking time for any 
woman. In addition to the loss of the pregnancy, there 
may be acute and chronic implications for both general 
and reproductive health. All identified risk factors in the 
many multiple studies are to date maternal: Chlamydia 
trachomatis infection, pelvic inflammatory disease, 
smoking, tubal surgery, assisted reproductive techniques, 
previous miscarriages, previous dilatation and curettage 
and endometriosis. The risk of recurrent EP is greatly 
increased compared to that of primary EP and reported 
incidence ranges from 6 to 18  %, with a trend towards 
higher rates of recurrence after salpingotomy (Jurko-
vic and Wilkinson 2011; Ankum et  al. 1996; Schoen 
and Nowak 1975). In spite of its identification as being 
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contributory to risk the incidence and occurrence of 
recurrent EP has not been assessed in research. The chal-
lenge of secondary prevention is related to a paucity of 
modifiable risk factors.
The purpose of our study is to determine whether 
there is a significant difference in patient demographics, 
clinical presentation, risk factors and surgical findings 
between women presenting with primary or recurrent 
EP. If present, this may help to pre operatively identify 
women likely to have a recurrent EP.
Objectives
To determine whether recurrent EP is associated with 
any significant differences in patient demographics, clini-
cal presentation, risk factors and surgical findings when 
compared to primary EP.
Methods
Study design
A retrospective case–control study of all EPs diagnosed 
from January 2003 to July 2014, at Whipps Cross Uni-
versity Hospital, London. Data for each surgically man-
aged case of EP presenting to the hospital was entered 
prospectively into a dedicated database. Exclusion crite-
ria included: non-surgically managed EP and incomplete 
dataset.
Patient details were collated and variables were col-
lected as below in Table 1.
Statistical analysis
Data was collected and stored on an Excel spreadsheet. 
Caldicott guidelines were strictly adhering to in the col-
lection and storage of personal information (Crook 
2003). Results were analyzed and compared using the 
Student’s t test and Fisher’s test. Parametric tests were 
used, as all data passed the test of normality. Student’s t 
test was used for numerical data and Fisher’s exact test 
for categorical data. Significance was set at a p value of 
<0.05. Multivariate logistic regression analysis was per-
formed using the significant variables from the univariate 
analysis. Analysis was performed using Graphpad Prism, 
Version 6.0 (Graphpad software, San Diego, USA).
Results
There were 849 consecutive EPs diagnosed and managed 
surgically from January 2003 to July 2014. Of these, 758 
were primary EPs and 91 were recurrent EPs. Of these 
52, 6.2 % of the study cohort was not tubal EPs: 29 cor-
nual and one repeat cornual EP, 19 ovarian with no recur-
rent EPs. There were 1 peritoneal, 2 CS scar ectopics, 1 
heterotropic and 1 rudimentary horn pregnancy. Non 
tubal and tubal EPs were analysed together.
Women with recurrent EPs were significantly 
older than women with primary EPs (32.2  ±  5.08 vs. 
30.5 ± 5.83 years, p < 0.05). They presented at a signifi-
cantly earlier gestation (5.99 ± 1.08 vs. 6.52 ± 1.81 weeks 
gestation, p < 0.05) and with a significantly lower primary 
βHCG (3176  ±  7350 vs. 6243  ±  12,282  IU/l, p  <  0.05) 
(Table 2).
There was no significant difference in symptoms at the 
time of clinical presentation between women with pri-
mary or recurrent EP. However, there was a non-signifi-
cant trend towards a greater proportion of patients with 
primary EP presenting with shoulder tip pain (10.5  % 
of primary EPs vs. 4.4  % of recurrent EPs, p  =  0.089) 
(Table  2). This is presumably in keeping with women 
with primary EPs presenting with a significantly greater 
volume of hemoperitoneum (see Table  3). Women with 
recurrent EPs had a significantly lower primary βHCG, in 
association with the significantly earlier gestation at time 
of clinical presentation (Table 2). Women with recurrent 
EP were also significantly more likely to have a transvagi-
nal ultrasound scan.
Women with recurrent EP were unsurprisingly sig-
nificantly more likely to have had previous tubal sur-
gery or previous pelvic surgery (Table 2). However, there 
was otherwise no significant difference in risk factors 
between women presenting with recurrent or primary 
EP. It is noteworthy that women with recurrent EP were 
not significantly more likely to have had previous pelvic 
inflammatory disease (Table 2).
There were no significant differences in scan findings 
between the two sub-groups (Table 2). At the time of sur-
gery, primary EP was significantly associated with greater 
volume of hemoperitoneum (592 ± 850 vs. 249 ± 391 ml, 
p  <  0.05). Women with recurrent EP were significantly 
more likely to have contralateral pathology (31.1 vs. 
9.8  %, p  <  0.05) and there was a non-significant trend 
towards a greater proportion of peri-hepatic adhesions 
(13.5 vs. 7.6 %, p = 0.066). In association with the desire 
to preserve future fertility, women with recurrent EP 
were significantly less likely to have a salpingectomy (57.1 
vs. 83.3 %, p < 0.05) and significantly more likely to have a 
salpingotomy (37.4 vs. 10.9 %, p < 0.05) (see Table 3).
The significant preoperative factors from the univariate 
analysis were entered into a logistic regression analysis. 
The predicted probabilities from the same were used to 
construct a ROC curve (Fig. 1). The AUC calculated was 
0.844, which indicates good differentiation between the 
two groups. Thus the parameters of age, gestational age 
at presentation, level of first βHCG, positive history of 
previous tubal surgery and previous EP differ in women 
at risk of a recurrent EP when compared to women not at 
risk of a recurrent ectopic (Table 4).
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Discussion
Our study shows that women with recurrent EP may 
represent a distinct subgroup of patients with EP. This is 
particularly in relation to awareness of the condition and 
early presentation, as they are significantly more likely to 
present at an earlier gestation, with a lower βHCG and 
significantly less hemoperitoneum. Universally, women 
treated for EP are informed of the approximately 10  % 
risk of recurrence of EP and they are advised to have an 
early pregnancy ultrasound scan in any future pregnancy. 
Our results contrast with a previous study of recurrent 
EP, which found a non-significant trend towards a higher 
βHCG (Butts et al. 2003). These contrasting results may 
represent our thorough post-operative counseling and 
Table 1 Patient details and variables
Variable Type of variable Primary  
[P]/secondary [S]
Description Units of measurement 
[P present, A absent]
Age Demographic characteristic P Age of each patient Years
Parity Demographic characteristic P No of deliveries Number
Gestation Demographic characteristic P Number of weeks of pregnancy Weeks
Pain Clinical characteristic P Presenting with abdominal pain P/A
Vomiting Clinical characteristic P In association with the other symp-
toms
P/A
Bleeding Clinical characteristic P Vaginal bleeding P/A
Diarrhoea Clinical characteristic P In association with the other symp-
toms
P/A
Shoulder tip pain Clinical characteristic P in association with the other symp-
toms
P/A
Syncope Clinical characteristic P In association with the other symp-
toms
P/A
Smoking Risk factor P Known long term smoking P/A
Previous tubal surgery Risk factor P Due to previous tubal pathology P/A
Previous pelvic surgery Risk factor P Due to previous pelvic pathology P/A
Previous miscarriage Risk factor P Diagnosed as miscarriage by scan 
and histopathology
P/A
Previous termination of 
pregnancy
Risk factor P Diagnosed as intra uterine pregnancy 
by scan and histopathology
P/A
Assisted reproduction Risk factor P Previous pathology P/A
Previous infertility Risk factor P Previous pathology P/A
Pelvic inflammatory disease Risk factor P Previous pathology P/A
Use of intrauterine contra-
ceptive device
Risk factor P As contraceptive P/A
Initial beta HCG level Investigation S Blood test mIU/ml
Transvaginal/trans-abdomi-
nal scan
Investigation S Ultrasound scan Performed/ 
not performed
Adnexal mass Investigation S Scan finding P/A
Gestational sac Investigation S Scan finding P/A
Fetal heartbeat Investigation S Scan finding P/A
Fluid in Pouch of Douglas Investigation S Scan finding P/A
Empty uterus Investigation S Scan finding P/A
Hemoperitoneum Investigation S Scan findings P/A
Laparotomy Treatment S Intra operative findings P/A
Tubal ectopic pregnancy Treatment S Intra operative findings P/A
Salpingectomy Treatment S Intra operative findings P/A
Salpingotomy Treatment S Intra operative findings P/A
Hemoperitoneum Treatment S Intra operative findings P/A
Presence of hepatic adhe-
sions
Treatment S Intra operative findings P/A
Contralateral pathology Treatment S Intra operative findings P/A
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follow up. The lower βHCG level may reflect an earlier 
presentation of the women due to our stringent fol-
low up protocol and counseling. Women are seen post 
operatively in a dedicated clinic or are telephoned in 
our dedicated telephone clinic and debriefed about their 
diagnosis and treatment. They are advised on the clinical 
course to follow with the next pregnancy, including get-
ting in touch with their general practitioner as soon as 
the pregnancy test becomes positive. An early ultrasound 
scan is arranged to facilitate early diagnosis. This indi-
cates that women are being diagnosed at an earlier stage 
when more tubal preservation could take place.
Table 2 The comparison of the baseline characteristics
The comparison of the baseline characteristics, risk factors, the clinical presentations and ultrasound scan findings of women presenting with primary EP compared 
with recurrent EP
TVS transvaginal ultrasound scan, TAS transabdominal ultrasound scan, PID pelvic inflammatory disease, IUD intrauterine device, FH fetal heartbeat, PoD pouch of 
douglas
a Data shown as mean (SD) and analysed by Student’s t test, with mean difference and 95 % confidence interval
b Data shown as % and analysed by Fisher’s exact test with Odds ratio (OR) and 95 % confidence interval
Recurrent ectopic Primary ectopic
Mean (±SD) or % (n) Mean (±SD) or % (n) p value Mean difference  
or odds ratio
95 % CI
Baseline characteristics of women with EP
 Agea 32.2 (5.08) 30.5 (5.83) 0.0049 −1.65 −2.78 to −0.51
 Parity 1b
 P0 37.5 (33/88) 44.7 (327/732) 0.2127 0.7431 0.471 to 1.172
 P1–P3 54.5 (48/88) 51.8 (379/732) 0.6526 1.118 0.717 to 1.742
 P4 or more 8.0 (7/88) 3.6 (26/732) 0.0755 2.347 0.9872 to 5.578
 Gestationa 5.99 (1.08) 6.52 (1.81) 0.0001 0.5402 0.2728 to 0.8076
Risk factors for EP in women with primary and recurrent EP
 Smoking 18.7 (17/91) 14.6 (108/741) 0.3498 1.346 0.7650 to 2.370
 Previous tubal surgery 61.4 (54/88) 3.5 (26/740) <0.0001 43.62 24.40 to 77.97
 Previous pelvic surgery 53.8 (49/91) 14.0 (104/743) <0.0001 7.168 4.519 to 11.37
 Previous miscarriage 27.5 (25/91) 24.1 (179/742) 0.5185 1.191 0.7297 to 1.945
 Previous TOP 14.3 (13/91) 18.7 (139/743) 0.3875 0.7242 0.3913 to 1.340
 Assisted reproduction 3.3 (3/91) 4.3 (32/743) 1.0 0.7575 0.2272 to 2.526
 Previous infertility 12.1 (11/91) 7.8 (58/743) 0.1602 1.624 0.8186 to 3.222
 Previous PID 8.8 (8/91) 7.7 (57/742) 0.6794 1.158 0.5339 to 2.513
 IUD 0 % 1.3 % (10/733) 0.6121 2.62 0.1521 to 45.11
 Mirena coil 0 % 0.9 % (7/743) 1 1.864 0.1055 to 32.92
Clinical presentation of women with primary and recurrent EP
 Painb 93.4 (85/91) 94.5 (705/746) 0.63 0.8239 0.3397 to 1.998
 Bleedingb 80.2 (73/91) 85.0 (634/746) 0.2239 0.7164 0.4118 to 1.246
 Vomitingb 7.7 (7/91) 9.7 (72/746) 0.7041 0.7801 0.3475 to 1.751
 Diarrhoeab 0 (0/91) 1.9 (14/746) 0.3849 0.2761 0.01632 to 4.670
 Shoulder tip painb 4.4 (4/91) 10.5 (78/745) 0.0899 0.3932 0.1404 to 1.101
 Syncopal attackb 6.6 (6/91) 11.1 (83/745) 0.2112 0.563 0.2385 to 1.329
 1st βHCGa 3176 (7350) 6243 (12,282) 0.0099 3053 750 to 5355
 TVSb 95.6 (87/91) 88.3 (651/737) 0.0323 0.348 0.1246 to 0.9724
 TASb 12.1 (11/91) 17.1 (126/738) 0.2943 1.497 0.7747 to 2.894
 Both TVS and TASb 11.0 (10/91) 12.0 (88/735) 1 1.102 0.5505 to 2.205
Ultrasound scan findings
 Adnexal massb 84.6 (77/91) 88.6 (643/726) 0.3007 1.409 0.7624 to 2.602
 Gest sacb 24.2 (22/91) 20.3 (148/730) 0.4104 0.7976 0.4776 to 1.332
 FHb 12.1 (11/91) 8.9 (65/730) 0.3363 0.7109 0.3602 to 1.403
 PoD fluidb 68.1 (62/91) 76.3 (557/730) 0.094 1.506 0.9385 to 2.417
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Women with recurrent EP were significantly older and 
a greater proportion was parous, although this did not 
reach statistically significance. This is consistent with the 
study by Butts et al. (Butts et al. 2003). In the UK, parous 
women are excluded from assisted conception treatment 
on the National Health Service and therefore everything 
should be done to preserve the affected tube, with the 
necessary surgical expertise available for management 
(Fertility: assessment and treatment for people with fer-
tility problems 2013; Odejinmi et  al. 2008). The ESEP 
study found that in women with a tubal pregnancy and 
a healthy contralateral tube, salpingotomy does not sig-
nificantly improve fertility prospects compared with sal-
pingectomy (Mol et al. 2014). Though the limitations of 
the ESEP study should be taken into consideration when 
managing these groups of women (Odejinmi 2014).
Unsurprisingly, women with EP were significantly 
more likely to have contralateral tubal pathology. There 
has always been some debate as to what type of surgery 
should be performed in women with a damaged con-
tralateral tube (The Management of Tubal Pregnancy 
2004). The consensus is that women should be treated 
on an individual basis with informed consent. If the con-
tralateral tube is damaged and preservation of fertility 
is a priority, then a salpingotomy is advised, as although 
this increases the chance of recurrent EP to 20  %, the 
chance of intrauterine pregnancy is 50  %. Extrapola-
tion from this would mean that if women have a recur-
rent EP, ideally they should have a salpingotomy, which 
again needs additional surgical expertise. Although in 
the short-term a salpingotomy is more expensive, due 
Table 3 Operative findings
The intra operative findings of women presenting with primary EP compared with recurrent EP
a Data shown as  % and analysed by Fisher’s exact test with odds ratio (OR) and 95 % confidence interval
b Data shown as mean (SD) and analysed by Student’s t test, with mean difference and 95 % confidence interval
Recurrent ectopic Primary ectopic
% (n) % (n) p value Mean difference  
or odds ratio
95 % CI
Presence of haemoperitoneuma 89.9 (80/89) 89.8 (654/728) 1 1.006 0.4847–2.087
Volume of haemoperitoneum (mls)b 249 (391) 592 (850) <0.0001 360.6 249.7–471.4
Presence of hepatic adhesionsa 13.5 (12/89) 7.6 (53/695) 0.0666 1.888 0.9661–3.689
Contralateral pathologya 31.1 (28/90) 9.8 (74/755) <0.0001 4.156 2.504–6.899
Laparotomya 1.1 (1/90) 4.5 (34/756) 0.1642 0.2386 0.03225–1.765
Tubal ectopica 97.8 (89/91) 93.3 (705/756) 0.1082 3.219 0.7702–13.46
Salpingectomya 57.1 (52/91) 83.3 (625/750) <0.0001 0.2667 0.1688–0.4214
Salpingotomya 37.4 (34/91) 10.9 (82/750) <0.0001 4.859 2.998–7.875
Fig. 1 Area under the curve AUC, 0.844. It shows the ROC curve 
obtained from the predicted probabilities of the logistic regression
Table 4 Logistic regression analysis
The logistic regression analysis results of the variables which were significant of 
univariate analysis
Parameter Odds ratio STD error p value 95 % CI
Lower Upper
Age 1.085 0.033 0.008 0.021 0.142
Gestation 0.808 0.101 0.090 −0.459 0.033
Previous tubal 
surgery
21.133 9.473 0.000 2.172 3.929
Previous pelvic 
surgery
2.455 1.008 0.029 0.093 1.703
First βHCG 1.000 0.000 0.058 0.000 0.000
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to additional post-operative follow up and treatment for 
persistent trophoblast that may become necessary, the 
reduced need for assisted conception renders this treat-
ment more cost-effective in the long-term (The Manage-
ment of Tubal Pregnancy 2004; Mol et al. 1997).
The results from our logistic regression analysis of sig-
nificant pre-operative characteristics emphasize that the 
groups are significantly different. Women with recurrent 
EP are more likely to be older, with a positive history of 
previous tubal or pelvic surgery and to present at an ear-
lier gestation with a lower βHCG. Therefore, it is para-
mount that transvaginal ultrasonography is performed 
by a sufficiently experienced practitioner and if surgical 
management is considered, then the necessary surgical 
expertise is available (Odejinmi et  al. 2008; Brown and 
Doubilet 1994; Crochet et al. 2013).
It is somewhat surprising that there was no significant 
difference in the history of previous pelvic inflammatory 
disease (PID) between the two groups. One might expect 
that women with recurrent EP would be more likely to 
have a history of previous PID or any other pathology 
that would be directly responsible for recurrence. Our 
finding is consistent with some of the literature (Butts 
et al. 2003; Joesoef et al. 1991), but contrasts with another 
large study of recurrent EP, which found that a history 
of infectious pathology tripled the risk of recurrent EP 
(Skjeldestad et  al. 1998). Possible explanations for this 
include the fact that sexually transmitted infections and 
PID are notoriously both under-reported and under-
diagnosed (Bouyer et al. 2003). This is one of the facets 
of contributing risk which was not explored in our study. 
Our protocol for patient management during investiga-
tion and management for an EP included investigations 
for Chlamydia only if there was a positive history of pre-
vious/recent PID. Thus along with the majority of simi-
lar studies, actual numbers of infections could have been 
under reported in our study. In a previous study of EP, 
although less than 10 % of patients gave a history of PID/
salpingitis, over 75 % were found to have antibodies to N 
gonorrhoea or C trachomatis, suggesting that infection is 
commonly sub-clinical (Spandorfer and Barnhart 2003). 
The link with sub-clinical PID and EP has been evidenced 
(Sweet and Gibbs 2012). And therefore, it is possible that 
a significant proportion of our patients had sub-clinical 
PID and that our results on history of previous PID are 
therefore unreliable. The significant impact on future 
reproductive health, including recurrent EP, emphasizes 
the importance of establishing a history of PID and regu-
larly testing for sexually transmitted infections, even in 
apparently low risk women.
When considering other established risk factors for EP, 
there was no statistically significant difference in risk fac-
tors between the two groups, except for previous tubal or 
pelvic surgery. However, there were a marginally higher 
proportion of smokers, women with a previous miscar-
riage and women with previous subfertility in the group 
with recurrent EP. Conversely, there were 17 women out 
of 758 with a primary EP who had a Mirena or copper 
coil in  situ, compared to 0  % of women with recurrent 
EPs (again, this did not reach statistical significance). This 
may represent the fact that women who have already had 
one EP do not wish to expose themselves to anything 
else which may increase their risk of ectopic implanta-
tion (Bouyer et  al. 2003; Bouyer et  al. 2000; Mol et  al. 
1995; Parashi et  al. 2014). Women who want to avoid a 
recurrent EP and need contraception sometimes opt for 
an implant but this also has its drawbacks as it has been 
shown that although the failure rate is extremely low the 
risk of EP is still present (Olowu et al. 2011). The review 
by Rana et  al. showed that surgically managed EPs are 
decreasing and not the actual incidence of EP (Rana et al. 
2013).
Our study is limited by the fact that we have only 
included women who have had a surgically managed EP. 
Therefore, we are missing women with a recurrent EP 
who had conservative or medical management of their 
EP. At our unit, we have been collecting data on con-
servative or medical management since 2009—during 
this period there have been 13 recurrent EPs that were 
managed with conservative or medical management. 
Nevertheless, our cohort represents the largest study of 
recurrent EP in the literature. Expecting a recurrent EP 
pre operatively is of importance in planning the surgical 
outcome as many tubal preservation techniques are being 
used successfully (Watrowski 2014).
The non-tubal as well as the tubal EPs were consid-
ered together. The risk factors and etiology of non tubal 
and tubal implantation are not significantly different. 
The symptoms and signs of non tubal ectopic pregnancy 
do not significantly differ from those of tubal pregnan-
cies though they tend to present later. The symptoms 
are similar and the only significant differences are due 
to the delayed diagnosis leading to accentuation of the 
symptoms at presentation (Alalade et al. 2015). Due to all 
the above factors it was felt that excluding non tubal EPs 
from the analysis would introduce bias.
One of the limitations of our study is that one of pri-
mary ectopic pregnancies if followed up for a further 
number of years could develop a recurrent ectopic. This 
bias in our study is limited by the fact that the num-
bers of primary ectopics are significantly greater than 
that of the recurrent ectopics. Additionally none of the 
primary ectopic pregnancies have developed another 
ectopic since July 2014. A better study design would be 
a cohort study, including patients who have their first 
ectopic pregnancy during a specific period of time and 
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subsequently observed during a certain number of years 
in order to differentiate those patients who have recur-
rent ectopic pregnancies from those who do not have 
more ectopic pregnancies.
In conclusion, we have demonstrated that women with 
recurrent EP represent a unique sub-group of women 
with EP. They are older, more likely to present at an ear-
lier gestation, with a lower initial βHCG and significantly 
less hemoperitoneum. We found no significant difference 
in symptoms at presentation, or in risk factors present—
except for a history of tubal or pelvic surgery. Unfortu-
nately, there is a paucity of modifiable risk factors for 
secondary prevention of recurrent EP. The implications 
for future reproductive health require women with recur-
rent EP to be rapidly identified and managed with the 
appropriate level of surgical expertise.
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